These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 15593249)

  • 1. Feasibility and construct validity of the parent willingness-to-pay technique for children with juvenile idiopathic arthritis.
    Barron AC; Lee TL; Taylor J; Moore T; Passo MH; Graham TB; Griffin TA; Grom AA; Lovell DJ; Brunner HI
    Arthritis Rheum; 2004 Dec; 51(6):899-908. PubMed ID: 15593249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study.
    Hu SW; Holt EW; Husni ME; Qureshi AA
    Semin Arthritis Rheum; 2010 Apr; 39(5):384-97. PubMed ID: 19095293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life, physical function, fatigue, and disease activity in children with established polyarticular juvenile idiopathic arthritis.
    Ringold S; Wallace CA; Rivara FP
    J Rheumatol; 2009 Jun; 36(6):1330-6. PubMed ID: 19411394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective.
    Fautrel B; Clarke AE; Guillemin F; Adam V; St-Pierre Y; Panaritis T; Fortin PR; Menard HA; Donaldson C; Penrod JR
    J Rheumatol; 2005 Mar; 32(3):443-53. PubMed ID: 15742435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do utility values and willingness to pay suitably reflect health outcome in hip and knee osteoarthritis? A comparative analysis with the WOMAC Index.
    Ethgen O; Tancredi A; Lejeune E; Kvasz A; Zegels B; Reginster JY
    J Rheumatol; 2003 Nov; 30(11):2452-9. PubMed ID: 14677192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis.
    Céspedes-Cruz A; Gutiérrez-Suárez R; Pistorio A; Ravelli A; Loy A; Murray KJ; Gerloni V; Wulffraat N; Oliveira S; Walsh J; Penades IC; Alpigiani MG; Lahdenne P; Saad-Magalhães C; Cortis E; Lepore L; Kimura Y; Wouters C; Martini A; Ruperto N;
    Ann Rheum Dis; 2008 Mar; 67(3):309-14. PubMed ID: 17875547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain experience and pain coping strategies in children with juvenile idiopathic arthritis.
    Thastum M; Zachariae R; Herlin T
    J Rheumatol; 2001 May; 28(5):1091-8. PubMed ID: 11361195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life of children with primary immunodeficiency disease: a comparison study.
    Zebracki K; Palermo TM; Hostoffer R; Duff K; Drotar D
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):557-61. PubMed ID: 15609765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What does "active disease" mean? patient and parent perceptions of disease activity in the systemic arthritis form of juvenile idiopathic arthritis (SO-JIA).
    Batthish M; Schneider R; Ramanan AV; Achonu C; Young NL; Feldman BM
    Rheumatology (Oxford); 2005 Jun; 44(6):796-9. PubMed ID: 15784631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growing up and moving on in rheumatology: parents as proxies of adolescents with juvenile idiopathic arthritis.
    Shaw KL; Southwood TR; McDonagh JE
    Arthritis Rheum; 2006 Apr; 55(2):189-98. PubMed ID: 16583398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parents' willingness to pay for diminishing children's pain during blood sampling.
    Wasserfallen JB; Currat-Zweifel C; Cheseaux JJ; Hofer M; Fanconi S
    Paediatr Anaesth; 2006 Jan; 16(1):11-8. PubMed ID: 16409523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring health status in early juvenile idiopathic arthritis: determinants and responsiveness of the child health questionnaire.
    Selvaag AM; Flatø B; Lien G; Sørskaar D; Vinje O; Førre Ø
    J Rheumatol; 2003 Jul; 30(7):1602-10. PubMed ID: 12858465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to pay for community-based health insurance in Nigeria: do economic status and place of residence matter?
    Onwujekwe O; Okereke E; Onoka C; Uzochukwu B; Kirigia J; Petu A
    Health Policy Plan; 2010 Mar; 25(2):155-61. PubMed ID: 20156920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study.
    Oen K; Tucker L; Huber AM; Miettunen P; Scuccimarri R; Campillo S; Cabral DA; Feldman BM; Tse S; Chédeville G; Spiegel L; Schneider R; Lang B; Ellsworth J; Ramsey S; Dancey P; Silverman E; Chetaille AL; Cameron B; Johnson N; Dorval J; Petty RE; Duffy KW; Boire G; Haddad E; Houghton K; Saint-Cyr C; Turvey SE; Benseler S; Cheang M; Yeung RS; Duffy CM
    Arthritis Rheum; 2009 Aug; 61(8):1077-86. PubMed ID: 19644903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parents' willingness to pay for biologic treatments in juvenile idiopathic arthritis.
    Burnett HF; Ungar WJ; Regier DA; Feldman BM; Miller FA
    Value Health; 2014 Dec; 17(8):830-7. PubMed ID: 25498778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and initial validation of composite parent- and child-centered disease assessment indices for juvenile idiopathic arthritis.
    Consolaro A; Ruperto N; Pistorio A; Lattanzi B; Solari N; Galasso R; Pederzoli S; Varnier GC; Dolezalova P; Alessio M; Burgos-Vargas R; Vesely R; Martini A; Ravelli A;
    Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1262-70. PubMed ID: 21618454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact on health-related quality of life from non-steroidal anti-inflammatory drugs, methotrexate, or steroids in treatment for juvenile idiopathic arthritis.
    Riddle R; Ryser CN; Morton AA; Sampson JD; Browne RH; Punaro MG; Gatchel RJ
    J Pediatr Psychol; 2006 Apr; 31(3):262-71. PubMed ID: 15872147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis.
    Viola S; Felici E; Magni-Manzoni S; Pistorio A; Buoncompagni A; Ruperto N; Rossi F; Bartoli M; Martini A; Ravelli A
    Arthritis Rheum; 2005 Jul; 52(7):2092-102. PubMed ID: 15986372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parents' preferences for drug treatments in juvenile idiopathic arthritis: a discrete choice experiment.
    Burnett HF; Regier DA; Feldman BM; Miller FA; Ungar WJ
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1382-91. PubMed ID: 22504893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient preferences for depression treatment programs and willingness to pay for treatment.
    Morey E; Thacher JA; Craighead WE
    J Ment Health Policy Econ; 2007 Jun; 10(2):73-85. PubMed ID: 17603148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.